Symptomatic osteonecrosis in childhood leukemia survivors: Prevalence, risk factors and impact on quality of life in adulthood

Haematologica

Volumn 98, Issue 7, 2013, Pages 1089-1097

  Girard, Pauline ^a,b   Auquier, Pascal ^c   Barlogis, Vincent ^a,c   Contet, Audrey ^d   Poire, Maryline ^e   Demeocq, François ^f   Berbis, Julie ^c   Herrmann, Iris ^a   Villes, Virginie ^c   Sirvent, Nicolas ^g   Kanold, Justyna ^f   Chastagner, Pascal ^d   Chambost, Hervé ^a   Plantaz, Dominique ^b   Michel, Gérard ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e UNIVERSITY HOSPITAL OF NICE   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; PREDNISONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BONE NECROSIS; CHILD; CHILDHOOD LEUKEMIA; FEMALE; FOLLOW UP; HEALTH; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; JOINT PROSTHESIS; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SICKNESS IMPACT PROFILE; SURVIVORS;

EID: 84879561599     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.081265     Document Type: Article

References (50)

1. Pui CH, Carroll WL, Meshinchi D, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29(5):551-65.
2. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-82.
3. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer. 1990;65(8):1717-21.
4. Körholz D, Bruder M, Engelbrecht V, Rüther W, Göbel U. Aseptic osteonecrosis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998;15(4):307-15.
5. Socié G, Sélimi F, Sedel L, Frija J, Devergie A, Esperou Bourdeau H, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol. 1994; 86(3):624-8.
6. Kadan-Lottick NS, Dinu I, Wasilewski- Masker K, Kaste S, Meacham S, Mahajan A, et al. Osteonecrosis in Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:3038-45.
7. Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer. 2008;50(2 Suppl):469-73.
8. Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol. 2007;25(12):1525-31.
9. Mitchell DG, Rao VM, Dalinka MK, Spritzer CE, Alavi A, Streinberg ME, et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology. 1987;162(3):709-15.
10. Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096-106.
11. McNeer JL, Nachman JB. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol. 2010;149(5):638-52.
12. Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G, et al. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica. 2010;95(9):1489-95.
13. Michel G, Bordigoni P, Simeoni MC, Curtillet C, Hoxha S, Robitail S, et al. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;40(9):897-904.
14. Haynes RC Jr, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Rall TW, et al. (eds): The Pharmacological Basis of Therapeutics (ed 7). New York, NY: Macmillan Publishing Company, 1985, pp. 1459-89.
15. Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066-72.
16. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Pääkkö EL, et al. Body Mass Index increases the risk of osteonecrosis in childrem with acute lymphoblastic leukemia. J Clin Oncol. 2007; 25(12):1498-504.
17. Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013-23.
18. Reulen RC, Zeegers MP, Jenkinson C, Lancashire ER, Winter DL, Jenney ME, et al. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability and scaling assumptions. Health Qual Life Outcomes. 2006;4:77.
19. Cohen J. Statistical power analysis for the behavioural sciences, 2nd ed. Lawrence Eribaum Associates Publishers, Hillsdale, NJ, USA. 1998.
20. Te Winkel ML, Pieters R, Hop WC, De Groot-Kruseman HA, Lequin MH, Van der Sluis IM, et al. Prospective study on incidence, risk factors and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011; 29(31):4143-50.
21. Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis:a treatment related toxicity in chilhood acute lymphoblastic leukemia (ALL), experiences from trail ALL-BFM 95. Pediatr Blood Cancer. 2005;44(3):220-5.
22. Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukemia: a UKALL XII analysis. Leukemia. 2008;22(2):308-12.
23. Tragiannidis A, Athanassiadou F, Papageorgiou T, Petsatodis G, Sidi V, Kolouskas D. Osteonecrosis in children with acute lymphoblastic leukemia: a 10 year study from Northern Greece. Pediatr Blood Cancer. 2007;49(5):764.
24. Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children's cancer group. J Clin Oncol. 2000; 18(18):3262-72.
25. Högler W, Wehl G, Van Staa T, Meister B, Klein-Franke A, Kropshofer G. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database. Pediatr Blood Cancer. 2007;48(1):21-7.
26. Te Winkel ML, Appel IM, Pieters R, Van den Heuvel-Eibrink MM. Impaired dexamethasone- related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lym- phoblastic leukemia. Haematologica. 2008; 93(10):1570-4.
27. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730-41.
28. Faraci M, Calevo MG, Lanino E, Caruso S, Messina C, Favr C, et al. Osteonecrosis after allogenic stem cell transplantation in childhood: a case control study in Italy. Haematologica. 2006;91(8):1096-9.
29. Sharma S, Leung WH, Deqing P, Yang J, Rochester R, Britton L, et al. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant. 2012;47 (8):1067-74.
30. Barr RD, Sala A. Osteonecrosis in children and adolescents with cancer. Pediatr Blood Cancer. 2008;50(2 Suppl):483-5.
31. Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, et al. Pharmacokinetic, pharmacodynamic and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117(8):2340-7.
32. French D, Hamilton LH, Mattano LA, Sather HN, Devidas M, Nachman JB, et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008; 111(9):4496-9.
33. Teuffel O, Kuster SP, Hunger SP, Conter V, Hitzier J, Ethier MC, et al. Dexamethasone versus Prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia. 2011;25(8):1232-8.
34. Elmantaser M, Stewart G, Young D, Duncan R, Gibson B, Ahmed SF. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia. Arch Dis Child. 2010;95(10):805-9.
35. Mattano LA Jr, Devidas M, Nachman JB, Sather HN, Hunger SP, Steinherz PG, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-15.
36. Van den Heuvel-Eibrink MM, Pieters R. Steroids and risk of osteonecrosis in ALL: take a break. Lancet Oncol. 2012; 13(9):855-7.
37. Schaison G, Sommelet D, Bancillon A, Perel Y, Leblanc T, Bergeron C, et al. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87. Leukemia. 1992;6(Suppl 2):148-52.
38. Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, et al. Prognostic factor for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the Fralle 93 study. J Clin Oncol. 2008; 26(9):1496-503.
39. Vilmer E, Suciu S, Ferster A, Bertrand Y, Cavé H, Thyss A, et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG EORTC report. Leukemia. 2000;14(12):2257-66.
40. Uyttebroeck A, Suciu S, Laureys G, Robert A, Pacquement H, Ferster A, et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur J Cancer. 2008;44(6):840-6.
41. De Moerloose B, Suciu S, Bertrand Y, Mazingue F, Robert A, Uyttebroeck A, et al. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase III trial 58951. Blood. 2010;116(1):36-44.
42. Hanada T, Horigome Y, Inudoh M, Takita H. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during Lasparaginase therapy. Eur J Pediatr. 1989; 149(3):162-3.
43. Pfeilschifter J, Diel JJ. Osteoporosis Due to Cancer Treatment: Pathogenesis and Management. J Clin Oncol. 2000;18(7): 1570-93.
44. Chiou SS, Jang RC, Liao YM, Yang P. Healthrelated quality of life and cognitive outcomes among child and adolescent survivors of leukemia. Support Care Cancer. 2010;18(12):1581-7.
45. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, et al. Long-term health-related outcomes in survivors of childhood cancer treated with hematopoietic cell transplantation (HCT) versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study and Childhood Cancer Survivor Study. Blood. 2011;118(5):1413-20.
46. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen W, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA. 2003;290(12):1583-92.
47. Hamidah A, Wing CY, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Health-related quality of life (HRQOL) among pediatric leukemia patients in Malaysia. Pediatr Blood Cancer. 2011;57(1):105-9.
48. De Vries MA, van Litsenburg RR, Huisman J, Grootenhuis MA, Versluys AB, Kaspers GJ, et al. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukemia: a prospective observational study. Health Qual Life Outcomes. 2008; 26;6:103.
49. Clarke SA, Skinner R, Guest J, Darbyshire P, Cooper J, Vora A, et al. Clinical outcomes and health-related quality of life (HRQOL) following haematopoietic stem cell transplantation (HSCT) for paediatric leukemia. Child Care Health. 2010;37(4):571-80.
50. Pallua S, Giesinger J, Oberguggenberger A, Kemmler G, Nachbaur D, Clausen J, et al. Impact of GVHD on quality of life in longterm survivors of haematopoietic transplantation. Bone Marrow Transplant. 2010; 45(10):1534-9.